Posts Tagged ‘migraine’
Pivotal Clinical Trials of Migraine Drugs: Are We Measuring the Same Thing?
An analysis of dozens of trials reveals important differences in endpoint selection and timing.
Read MoreShared Biopsychosocial Factors Underlie Many Different Types of Chronic Pain, Including Headache
A new study uses machine learning to predict the development and spread of chronic pain based on a shared set of mental health, sociodemographic, and physical health factors.
Read MoreThe Migraine Science Collaborative Celebrates Its One-Year Anniversary: What Were You Reading over the Past Twelve Months?
One year after the launch of the new MSC website, news stories on psychedelics, CGRP inhibition, and artificial intelligence take the first three spots in our Top 10 list.
Read MoreThe Burden of Chronic Pain: Many New Cases, Lots of Persistence
In the first study of its kind, researchers examine chronic pain incidence and persistence in a nationally representative sample of adults in the United States. It’s likely the burden of pain is much higher than reported in the study when taking migraine into account.
Read MoreResponding to Patient Questions: Is an AI Chatbot Better Than a Doctor?
A new study shows that ChatGPT provides higher-quality and more empathetic answers. Like healthcare professionals in other fields, those who care for people with migraine and headache need to take stock of this disruptive technology.
Read MoreA Neuroimmune Signaling Pathway Drives Chronic Headache
A new study in mice finds that CCL2-CCR2 signaling in macrophages and T cells sensitizes trigeminal ganglion neurons, driving chronic headache in migraine models. With synergistic effects on CGRP, the pathway could be a new therapeutic target for migraine.
Read MoreUnderstanding Chronic Pain in the LGBTQIA2S+ Community
A new analysis of chronic pain prevalence in sexual minority populations shows that people who identify as lesbian, gay, bisexual, or “something else” live with more pain than straight individuals. The work reveals substantial differences within those populations, too.
Read MoreThe Best and Most Gender-Affirming Headache Care: An Interview with Anna Pace
In this Migraine Science Collaborative interview, Dr. Anna Pace discusses what effective gender-affirming headache care should look like, headache medicine education, and much more.
Read MoreDoes CGRP Inhibition Quiet the “Migraine Brain”?
Three months of galcanezumab treatment reduced the incidence of premonitory symptoms and number of triggers followed by headache, even in patients classified as “non-responders” to the drug.
Read MoreAssociation between Blood Biomarkers and Migraine in Patients with Tinnitus
Learn about new research from Cynthia Tsang, winner of a 2023 MSC Travel Grant supporting travel to the 65th Annual Scientific Meeting of the American Headache Society.
Read More